OCUL
Ocular Therapeutix, Inc. · Healthcare
Chief Scientific Officer Jeffrey S. Heier sold $36K of Ocular Therapeutix, Inc.
Sold$35,531
$10.78Price
3,296Shares
−1%Stake
What OCUL did after the filing
- The stock from Thu, Aug 27 open, $10.63
- −29.1%
- S&P 500, same days
- +1.3%
Measured over 30 trading days, to the Oct 9 close.
Traded Mon, Aug 24. Filed Wed, Aug 26, 5:57 PM ET, after the close. Returns use the Aug 27 open and the Oct 9 close. Not investment advice.